A syringe pump made by a Minneapolis-based company is being recalled for risks that could cause life-threatening injuries or death. The Food and Drug Administration (FDA) issued a Class I correction ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Smiths Medical, a leading global medical device manufacturer, announced today it received a license from Health Canada and launched its Medfusion ® 4000 syringe ...
For the fourth time already this month, the FDA has issued a notice formally bestowing a Class I label—denoting a heightened risk of serious injury or death—upon a recall of yet another drug delivery ...
The Food and Drug Administration has classified a recall of about 600 pediatric drug-infusion pumps made by Plymouth-based Smiths Medical as a Class 1 recall, meaning that a software problem in the ...
The U.S. Food and Drug Administration (FDA) this week issued a Class I recall — its most serious — for the Medfusion syringe pump, the agency’s third major recall of the line of devices made in ...
LONDON--(BUSINESS WIRE)--The global smart syringe pumps market is expected to post a CAGR of nearly 9% during the forecast period 2019-2023, according to the latest market research report by Technavio ...
The FDA is spotlighting a new medical device correction effort at Baxter over its large-volume Novum IQ infusion pump, following reports of 79 serious injuries and two deaths linked to potential under ...
Nov 20 (Reuters) - The U.S. Food and Drug Administration on Monday warned healthcare providers and facilities not to use Cardinal Health's (CAH.N), opens new tab Monoject syringes with ...
This tutorial discusses critical considerations requiring attention when designing an infusion pump, including FDA regulation, self-test circuitry, and meeting the IEC 60601-1 standard for electrical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback